How does subintimal angioplasty compare to transluminal angioplasty for the treatment of femoral occlusive disease?
A best evidence topic in surgery was written according to a structured protocol. The question addressed how subintimal angioplasty (SIA) compares to transluminal angioplasty (TA) for the treatment of femoral occlusive disease. One hundred and thirty two papers were found using the reported search; the 5 which represented the best evidence to answer the question are discussed. The evidence on this subject is limited; there are no randomised controlled trials (RCTs) comparing SIA to TA for pathologically equivalent lesions. However SIA remains a safe and effective alternative to surgical bypass grafting when TA cannot be performed.
Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
S G
SG
Klimach
The Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK. Electronic address: n.gollop@doctors.org.uk.
N D
ND
Gollop
The Queen Elizabeth Hospital, King's Lynn, Norfolk, UK.
J
J
Ellis
The Queen Elizabeth Hospital, King's Lynn, Norfolk, UK.
P
P
Cathcart
D017130:Angioplasty / Q000379:methods*; D001157:Arterial Occlusive Diseases / Q000601:surgery*; D015331:Cohort Studies; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D016896:Treatment Outcome
Femoral occlusive disease; Subintimal angioplasty; Transluminal angioplasty